Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119978) titled 'Application study of different concentrations of bupivacaine liposomes combined with proximal adductor canal and anserine tendon block in anterior cruciate ligament reconstruction under knee arthroscopy' on March 6.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Guangxi Medical University
Condition:
Ruptured anterior cruciate ligament
Intervention:
Group N1:Preoperatively, 15 ml of 0.333% bupivacaine liposome was used for proximal adductor canal block + pes anserinus block.
Group N2:Preoperatively, 15 ml of 0.443% bupivacaine liposome was used for...